Article
Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment
2025-06-18
Abstract excerpt
<h4>Background: </h4> Cutaneous leishmaniasis (CL), a neglected infectious disease caused by the intracellular protozoan parasite Leishmania, affects over one million people annually. The type and magnitude of the inflammatory response elicited during infection leads to skin-specific immunopathology, resulting in the clinical manifestations of CL. Systemic antileishmanial drugs are the main control measure; howev...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ec2cae2a-d243-5efa-b229-ef27ed19fd9a
- DOI
- 10.22541/au.175024995.51140065/v1
